HROW with a nice impulsive, 5-wave move off the low. HROW needs to hold the 0.618 retracement ($18.75) on this pull back, followed by a rally above the $19.95 local peak set today for further confirmation. Very bullish on the long-term prospects of this ticker.
This strategy dissects the dual nature of big pharmaceutical firms like Johnson & Johnson, Pfizer, Moderna, and Merck & Co viewed through base Fibonacci Extension Clustering. Despite big pharma's significant contributions to healthcare, these firms have benefited from questionable practices, including price manipulation and exploiting addictions . Price...
VRPX was on a downtrend from mid-February into a reversal the beginning of May. VRPX beat earnings up still has no cash flow which is very common in this subsector. VRPX is priced on the potential of future earnings. The short and long-moving averages ratio shows bullish momentum also shows strength with an upper Bollinger Band "walk". Price has climbed...
Stock Aridis Pharmaceuticals Inc. NASDAQ:ARDS (low float stock)
MGRX a recent IPO produces a med for erectile dysfunction without FDA approval; They are basically selling a generic version of an approved medication and bypassing the patent protections and betting they will fly under the regulator radar apparatus. As might be expeted this recent nano-IPO is highlly volatile. Play with it only if you have the requisite...
- Big initial move right of out the gate - ~1 month consolidation - Confluence of MAs - New Momentum - High ADR - Pharma
NASDAQ:BBIO tight action. Pharma has been popping as of late - hopefully that continues. Anticipation set-up.
Tight Action on $UNCY. Massive run up on big volume and holding level.
$AUPH AUPH inside days after good run up and decent beat. Liquid and increasing institutional interest.
AmerisourceBergen is a pharma company with superb growth and financials. Healthcare sector has been deeply sold off. This is a strong trending stock on the weekly (see 52 week EMA Red line). I look to add a small starter position at 154.46, the Gann Confluence Line. Will add another position should it reach either the 52 Week EMA or a RSI (12) weekly of 39 - 40....
Inv Head and Shoulders formed on Adcock and now the price is above the neckline showing upside to come. 7>21>200 RSI>50 Bullish CONCERNS: This is a very volatile, flimsy and illiquid stock compared to the Blue Chips. I call these unhealthy charts which seldom work well with breakout patterns. Maybe as a Weekly analysis or Monthly will show some more promising...
The technical figure Channel Up can be found in the daily chart in the French company Sanofi S.A. (SAN.pa). Sanofi S.A. is a French multinational pharmaceutical and healthcare company. Sanofi engages in the research and development, manufacturing and marketing of pharmacological products, principally in the prescription market, but the firm also develops...
Hey traders, My weekly trade idea. The daily price is forming a textbook Cup&Handle formation. After the consolidation in the handle phase, the price is ready to go higher. The momentum will push the price and in my opinion, it is headed to test the all-time high in the 180$ area. The Relative Strength Index broke above its trend line and is moving upward to...
The UnitedHealth Group (UNH) hit the Resistance Zone following our last (November 18) signal but as it failed to break through its top, it got rejected: By doing so, the price even broke below the Higher Lows trend-line and the Bullish Megaphone pattern, that were in effect since February 2021. This potentially signals a deceleration on its enormous and...
Hi Traders We can't say much here! As always history has shown us when a new drug goes on the market we have 3 scenarios: 1 we're going up (green path) 2 the medicine is not good we are going down (red path) 3 we don't know what the medicine is like until many people take it let's go sideways (purple path) with all that is happening at the moment we are...
Sanofi - 30d expiry - We look to Buy a break of 88.01 (stop at 84.48) Previous resistance level of 88 broken. Our short term bias remains positive. Previous resistance, now becomes support at 88. 50 1day EMA is at 86.97. Support is located at 88 and should stem dips to this area. Daily signals are mildly bullish. Our profit targets will be 96.72 and 97.72...
The Structure looks good to us, waiting for this instrument to correct and then give us these opportunities as shown on this instrument (Price Chart). Note: Its my view only and its for educational purpose only. Only who has got knowledge about this strategy, will understand what to be done on this setup. its purely based on my technical analysis only...
NYSE:PFE broke out at 45.60 and after hitting a high of 58, it then retested support in Oct 2022. It has now broken out and is heading higher.